Therapeutic nucleosides

Details Therapeutic nucleosides Therapeutic nucleosides

C - Chemistry, Metallurgy

07

H

167/202, 260/229

C07H 19/073 (2006.01) A61K 31/70 (2006.01) C07H 19/06 (2006.01)

Patent

CA 1321387

B507 ABSTRACT 1-(3-Azido-2,3-dideoxy-.beta.-D-erythro-pentofuranosyl)-5-methyl-2(1H)- pyrimidinone is capable of conversion in vivo to 3'-azido-3'-deoxythymidine (zidovudine) and is therefore useful in human medical therapy, e.g. in the treatment or prophylaxis of Human Immunodeficiency Virus (HIV) infections such as Acquired Immune Deficiency Syndrome (AIDS). MG/AC/B507ABST/24.02.88

561458

Affiliated with

Also associated with

Rating

Therapeutic nucleosides does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Therapeutic nucleosides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Therapeutic nucleosides will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1215801